Patents by Inventor Marion Elizabeth Andrew

Marion Elizabeth Andrew has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of improving the growth performance of an animal
    Publication number: 20040170601
    Abstract: The invention broadly relates to a method of improving the growth performance of an animal. In particular the present invention relates to a method of improving the growth performance of an animal comprising the step of administering to an animal in need thereof a growth promoting amount of one or more cytokines or biologically active fragments thereof.
    Type: Application
    Filed: April 5, 2004
    Publication date: September 2, 2004
    Inventors: Alan David Greve Strom, Marion Elizabeth Andrew, Aleta Gai Knowles
  • Recombinant vaccine
    Patent number: 5866131
    Abstract: A recombinant vaccine comprises a vaccine vector which incorporates a first nucleotide sequence capable of being expressed as all or a part of an antigenic polypeptide, together with a second nucleotide sequence capable of being expressed as all or a part of a lymphokine effective in enhancing the immune response to the antigenic polypeptide. The vaccine vectors include poxvirus, herpes virus or adenovirus, and the lymphokine may be an interleukin, tumour necrosis factor or gamma-interferon. The vaccine vector may express an antigenic polypeptide which is foreign to the host vector.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 2, 1999
    Assignees: Commonwealth Scientific and Industrial Research Organisation, The Australian National University
    Inventors: Ian Allister Ramshaw, David Bernard Boyle, Barbara Elizabeth Howieson Coupar, Marion Elizabeth Andrew
  • Recombinant vaccine
    Patent number: 5866136
    Abstract: A recombinant vaccine comprises a vaccine vector which incorporates a first nucleotide sequence capable of being expressed as all or a part of an antigenic polypeptide, together with a second nucleotide sequence capable of being expressed as all or a part of a lymphokine effective in enhancing the immune response to the antigenic polypeptide. The vaccine vectors include poxvirus, herpes virus or adenovirus, and the lymphokine may be an interleukin, tumour necrosis factor or gamma-interferon. The vaccine vector may express an antigenic polypeptide which is foreign to the host vector.
    Type: Grant
    Filed: November 9, 1990
    Date of Patent: February 2, 1999
    Assignees: Commonwealth Scientific and Industrial Organisation, The Australian National University
    Inventors: Ian Allister Ramshaw, David Bernard Boyle, Barbara Elizabeth Howieson Coupar, Marion Elizabeth Andrew